Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Immunotherapy With MK-3475 in Surgically Resectable Endometrial Carcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02630823
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:00.564240+00:00
Published At
2025-01-03T00:00:00+00:00
Record Updated At
2025-01-03
Results Posted At
2025-01-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Endometrial Cancer", "Endometrial Carcinoma", "Neoplasms, Endometrial"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-01-03"
protocolSection.identificationModule.nctId
"NCT02630823"
protocolSection.identificationModule.officialTitle
"Immunotherapy With MK-3475 in Surgically Resectable Endometrial Carcinoma"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-01-03"

Study condition terms

  • Endometrial Cancer (protocolSection.conditionsModule.conditions)
  • Endometrial Carcinoma (protocolSection.conditionsModule.conditions)
  • Neoplasms, Endometrial (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.